TW200633728A - Stable non-dihydrate azithromycin oral suspensions - Google Patents
Stable non-dihydrate azithromycin oral suspensionsInfo
- Publication number
- TW200633728A TW200633728A TW094145377A TW94145377A TW200633728A TW 200633728 A TW200633728 A TW 200633728A TW 094145377 A TW094145377 A TW 094145377A TW 94145377 A TW94145377 A TW 94145377A TW 200633728 A TW200633728 A TW 200633728A
- Authority
- TW
- Taiwan
- Prior art keywords
- azithromycin
- stable non
- oral suspensions
- dihydrate azithromycin
- dihydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63821804P | 2004-12-21 | 2004-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200633728A true TW200633728A (en) | 2006-10-01 |
Family
ID=36602128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094145377A TW200633728A (en) | 2004-12-21 | 2005-12-20 | Stable non-dihydrate azithromycin oral suspensions |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100048498A1 (zh) |
EP (1) | EP1830860A2 (zh) |
JP (1) | JP2008524318A (zh) |
AR (1) | AR052060A1 (zh) |
CA (1) | CA2591744A1 (zh) |
TW (1) | TW200633728A (zh) |
WO (1) | WO2006067577A2 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8278309B2 (en) | 2008-10-27 | 2012-10-02 | Polymedix, Inc. | Synthetic mimetics of host defense and uses thereof |
WO2010125212A1 (es) * | 2009-04-27 | 2010-11-04 | Laboratorio De Aplicaciones Farmacodinamicas, S.A. | Suspensión oral de lisinato de ibuprofeno |
WO2013088274A1 (en) | 2011-12-14 | 2013-06-20 | Wockhardt Limited | Anhydrous amorphous azithromycin composition free of azithromycin dihydrate |
KR20160079781A (ko) * | 2013-11-08 | 2016-07-06 | 액티버스 파마 컴퍼니 리미티드 | 매크롤라이드계 항균제의 나노미립자를 함유하는 수성 현탁액제 |
JP6711875B2 (ja) * | 2018-08-29 | 2020-06-17 | 日本食品化工株式会社 | マクロライド化合物の苦味抑制剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
CA2245398C (en) * | 1998-08-21 | 2002-01-29 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
CN1273142C (zh) * | 1998-11-30 | 2006-09-06 | 特瓦制药工业有限公司 | 阿齐霉素的乙醇化物,制备方法以及医药组合物 |
US6861413B2 (en) * | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
DE60232005D1 (de) * | 2001-10-18 | 2009-05-28 | Teva Pharma | Stabilisierte azithromycin-zusammensetzungen |
NZ532707A (en) * | 2001-12-21 | 2006-07-28 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
GB0214277D0 (en) * | 2002-06-20 | 2002-07-31 | Biochemie Gmbh | Organic compounds |
GB0224197D0 (en) * | 2002-10-17 | 2002-11-27 | Biochemie Gmbh | Organic compounds |
US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
-
2005
- 2005-12-09 CA CA002591744A patent/CA2591744A1/en not_active Abandoned
- 2005-12-09 JP JP2007547689A patent/JP2008524318A/ja not_active Withdrawn
- 2005-12-09 EP EP05811059A patent/EP1830860A2/en not_active Withdrawn
- 2005-12-09 US US11/722,279 patent/US20100048498A1/en not_active Abandoned
- 2005-12-09 WO PCT/IB2005/003767 patent/WO2006067577A2/en active Application Filing
- 2005-12-19 AR ARP050105334A patent/AR052060A1/es not_active Application Discontinuation
- 2005-12-20 TW TW094145377A patent/TW200633728A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AR052060A1 (es) | 2007-02-28 |
WO2006067577A3 (en) | 2006-12-28 |
EP1830860A2 (en) | 2007-09-12 |
CA2591744A1 (en) | 2006-06-29 |
JP2008524318A (ja) | 2008-07-10 |
US20100048498A1 (en) | 2010-02-25 |
WO2006067577A2 (en) | 2006-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200700086A (en) | Injectable non-aqueous suspension | |
EP1740156B8 (de) | Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform | |
HK1120016A1 (en) | Method for producing fullerene suspension | |
MX2008016039A (es) | Preparacion de glucano. | |
WO2007117503A3 (en) | Preparing nanoparticles and carbon nanotubes | |
TW200717389A (en) | Luminance adjustment | |
TW200714549A (en) | Method and apparatus for the production of ultrafine silica particles from solid silica powder and related coating compositions | |
WO2007025861A3 (de) | Modifizierte kohlenstoff-nanopartikel, verfahren zu deren herstellung und deren verwendung | |
GB0615922D0 (en) | Method for producing particles,particles,and sintered body | |
TW200801161A (en) | Gas-phase infiltration of phosphors into the pore system of inverse opals | |
SG150518A1 (en) | Macrolides and methods for producing same | |
WO2008008917A3 (en) | Hydroxyapatite particles | |
TW200633728A (en) | Stable non-dihydrate azithromycin oral suspensions | |
MX2007004137A (es) | Panel estructural ligero y metodo para fabricarlo. | |
UA87568C2 (ru) | Способ и его применение для борьбы с паразитами, паразитицидный порошок | |
UA91733C2 (ru) | Способ получения кристаллической формы орлистата | |
ZA200903637B (en) | Method for producing stable, high-purity molded bodies from pyrogenic metal oxides without the addition of binders | |
NO20060611L (no) | Stabile ikke-dihydratazitromycin oralsuspensjoner | |
TW200719381A (en) | Electrode system for a lamp | |
EP1930310A4 (en) | PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONALDEHYDE | |
WO2007008588A3 (en) | Omeprazole form b | |
TW200505399A (en) | Hydroxylapatite powder, porous body and method for preparing thereof | |
IL184942A0 (en) | Azithromycin powder for oral suspension compositions | |
ZA200801104B (en) | Method for the production of 2,4,6-trimercapto-1,3,5-triazine | |
MX2007007045A (es) | Estabilizador uv para pmma. |